Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.
To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI survei...
Saved in:
Main Authors: | Birgitte Freiesleben de Blasio, Bjørn G Iversen, Gianpaolo Scalia Tomba |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/49d191d8c84b45778a95a6a75f441f1a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.
by: Lamberto Manzoli, et al.
Published: (2011) -
Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
by: Lisa A Prosser, et al.
Published: (2011) -
US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
by: Supriya Kumar, et al.
Published: (2012) -
Methicillin-resistant Staphylococcus aureus (MRSA) is increasing in Norway: a time series analysis of reported MRSA and methicillin-sensitive S. aureus cases, 1997-2010.
by: John F Moxnes, et al.
Published: (2013) -
Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.
by: Wan-Ting Huang, et al.
Published: (2013)